Skip to content

Drybench Patent.

Patent and exclusivity dates from January to June 2035 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from January to June 2035 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured
14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2035July to December 2035

Listed patent expiry (331)

  • 2 Jan 2035 · NDA 208065 · OSIMERTINIB MESYLATE

    US 10,183,020, product and use patent

    patent.txt lines 8,049, 8,066
    Flags
    product use code U-1777
    Product numbers
    001, 002
  • 2 Jan 2035 · NDA 208065 · OSIMERTINIB MESYLATE

    US 10,183,020, product and use patent

    patent.txt lines 8,050, 8,067
    Flags
    product use code U-2289
    Product numbers
    001, 002
  • 2 Jan 2035 · NDA 208065 · OSIMERTINIB MESYLATE

    US 10,183,020, product and use patent

    patent.txt lines 8,051, 8,068
    Flags
    product use code U-3016
    Product numbers
    001, 002
  • 2 Jan 2035 · NDA 208065 · OSIMERTINIB MESYLATE

    US 10,183,020, product and use patent

    patent.txt lines 8,052, 8,069
    Flags
    product use code U-3823
    Product numbers
    001, 002
  • 2 Jan 2035 · NDA 208065 · OSIMERTINIB MESYLATE

    US 10,183,020, product and use patent

    patent.txt lines 8,053, 8,070
    Flags
    product use code U-4010
    Product numbers
    001, 002
  • 2 Jan 2035 · NDA 208624 · DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

    US 10,105,365, product and use patent

    patent.txt line 8,994
    Flags
    product use code U-1889
    Product numbers
    001
  • 2 Jan 2035 · NDA 208624 · DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

    US 9,333,204, product and use patent

    patent.txt line 9,010
    Flags
    product use code U-1889
    Product numbers
    001
  • 2 Jan 2035 · NDA 208624 · DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

    US 9,744,170, product and use patent

    patent.txt line 9,011
    Flags
    product use code U-1889
    Product numbers
    001
  • 3 Jan 2035 · NDA 216873 · MOMELOTINIB DIHYDROCHLORIDE

    US 8,486,941, substance and product and use patent

    patent.txt lines 19,026, 19,031, 19,036
    Flags
    substance product use code U-1201
    Product numbers
    001, 002, 003
  • 5 Jan 2035 · NDA 209449 · NITISINONE

    US 10,328,029, product and use patent

    patent.txt lines 10,385–10,387
    Flags
    product use code U-1836
    Product numbers
    001, 002, 003
  • 6 Jan 2035 · NDA 212320 · FERRIC MALTOL

    US 10,179,120, use patent

    patent.txt line 13,946
    Flags
    use code U-2603
    Product numbers
    001
  • 8 Jan 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US 10,179,127, product and use patent

    patent.txt line 16,463
    Flags
    product use code U-3454
    Product numbers
    001
  • 8 Jan 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US 10,702,511, product and use patent

    patent.txt line 16,464
    Flags
    product use code U-3454
    Product numbers
    001
  • 8 Jan 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US 10,765,750, product patent

    patent.txt line 16,465
    Flags
    product
    Product numbers
    001
  • 8 Jan 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US 11,197,849, product and use patent

    patent.txt line 16,467
    Flags
    product use code U-3454
    Product numbers
    001
  • 8 Jan 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US 11,793,798, product and use patent

    patent.txt line 16,469
    Flags
    product use code U-3454
    Product numbers
    001
  • 8 Jan 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US 12,295,946, product and use patent

    patent.txt line 16,471
    Flags
    product use code U-3454
    Product numbers
    001
  • 8 Jan 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US 9,415,038, product and use patent

    patent.txt line 16,474
    Flags
    product use code U-3454
    Product numbers
    001
  • 8 Jan 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US RE48183, product and use patent

    patent.txt line 16,475
    Flags
    product use code U-3454
    Product numbers
    001
  • 19 Jan 2035 · NDA 214900 · IBREXAFUNGERP CITRATE

    US 10,174,074, substance and product patent

    patent.txt line 16,300
    Flags
    substance product
    Product numbers
    001
  • 19 Jan 2035 · NDA 214900 · IBREXAFUNGERP CITRATE

    US 10,370,406, use patent

    patent.txt line 16,301
    Flags
    use code U-3159
    Product numbers
    001
  • 19 Jan 2035 · NDA 214900 · IBREXAFUNGERP CITRATE

    US 10,927,142, substance patent

    patent.txt line 16,302
    Flags
    substance
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 10,272,083, use patent

    patent.txt line 11,248
    Flags
    use code U-2519
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 10,272,083, use patent

    patent.txt line 11,249
    Flags
    use code U-2682
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 10,272,083, use patent

    patent.txt line 11,250
    Flags
    use code U-2683
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 10,272,083, use patent

    patent.txt line 11,251
    Flags
    use code U-2684
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 10,272,083, use patent

    patent.txt line 11,252
    Flags
    use code U-2685
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 10,272,083, use patent

    patent.txt line 11,253
    Flags
    use code U-2686
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 10,272,083, use patent

    patent.txt line 11,254
    Flags
    use code U-2687
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 10,272,083, use patent

    patent.txt line 11,255
    Flags
    use code U-4109
    Product numbers
    001
  • 21 Jan 2035 · NDA 210259 · ACALABRUTINIB

    US 11,771,696, use patent

    patent.txt line 11,262
    Flags
    use code U-3710
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 10,272,083, use patent

    patent.txt line 18,767
    Flags
    use code U-2519
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 10,272,083, use patent

    patent.txt line 18,768
    Flags
    use code U-2682
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 10,272,083, use patent

    patent.txt line 18,769
    Flags
    use code U-2683
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 10,272,083, use patent

    patent.txt line 18,770
    Flags
    use code U-2684
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 10,272,083, use patent

    patent.txt line 18,771
    Flags
    use code U-2685
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 10,272,083, use patent

    patent.txt line 18,772
    Flags
    use code U-2686
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 10,272,083, use patent

    patent.txt line 18,773
    Flags
    use code U-2687
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 10,272,083, use patent

    patent.txt line 18,774
    Flags
    use code U-4109
    Product numbers
    001
  • 21 Jan 2035 · NDA 216387 · ACALABRUTINIB MALEATE

    US 11,771,696, use patent

    patent.txt line 18,789
    Flags
    use code U-3710
    Product numbers
    001
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 10,287,258, substance and use patent

    patent.txt lines 20,210, 20,224
    Flags
    substance use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 10,669,245, substance and use patent

    patent.txt lines 20,211, 20,225
    Flags
    substance use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 11,655,221, product and use patent

    patent.txt lines 20,212, 20,226
    Flags
    product use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 11,655,222, substance and use patent

    patent.txt lines 20,213, 20,227
    Flags
    substance use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 11,655,223, substance and use patent

    patent.txt lines 20,214, 20,228
    Flags
    substance use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 11,655,224, product and use patent

    patent.txt lines 20,215, 20,229
    Flags
    product use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 11,673,871, product and use patent

    patent.txt lines 20,216, 20,230
    Flags
    product use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 11,773,069, product and use patent

    patent.txt lines 20,217, 20,231
    Flags
    product use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 11,814,359, substance and use patent

    patent.txt lines 20,218, 20,232
    Flags
    substance use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 12,054,465, substance and use patent

    patent.txt lines 20,219, 20,233
    Flags
    substance use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 217673 · BRENSOCATIB

    US 9,815,805, use patent

    patent.txt lines 20,223, 20,237
    Flags
    use code U-4257
    Product numbers
    001, 002
  • 21 Jan 2035 · NDA 218808 · CRINECERFONT

    US 10,905,690, use patent

    patent.txt lines 21,377, 21,382, 21,387
    Flags
    use code U-4049
    Product numbers
    001, 002, 003
  • 21 Jan 2035 · NDA 218808 · CRINECERFONT

    US 11,311,544, use patent

    patent.txt lines 21,378, 21,383, 21,388
    Flags
    use code U-4049
    Product numbers
    001, 002, 003
  • 21 Jan 2035 · NDA 218808 · CRINECERFONT

    US 11,730,739, use patent

    patent.txt lines 21,379, 21,384, 21,389
    Flags
    use code U-4049
    Product numbers
    001, 002, 003
  • 21 Jan 2035 · NDA 218820 · CRINECERFONT

    US 10,905,690, use patent

    patent.txt line 21,392
    Flags
    use code U-4049
    Product numbers
    001
  • 21 Jan 2035 · NDA 218820 · CRINECERFONT

    US 11,311,544, use patent

    patent.txt line 21,393
    Flags
    use code U-4049
    Product numbers
    001
  • 21 Jan 2035 · NDA 218820 · CRINECERFONT

    US 11,730,739, use patent

    patent.txt line 21,394
    Flags
    use code U-4049
    Product numbers
    001
  • 23 Jan 2035 · NDA 218213 · REPOTRECTINIB

    US RE50634, substance and product patent

    patent.txt lines 20,911, 20,917
    Flags
    substance product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 10,010,575, use patent

    patent.txt lines 4,787, 4,796, 4,805, 4,814
    Flags
    use code U-1857
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 12,186,362, product patent

    patent.txt lines 4,788, 4,797, 4,806, 4,815
    Flags
    product
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,375,478, use patent

    patent.txt lines 4,776, 4,781
    Flags
    use code U-1857
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,687,526, use patent

    patent.txt lines 4,777, 4,782
    Flags
    use code U-1857
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,744,209, use patent

    patent.txt lines 4,778, 4,783
    Flags
    use code U-1857
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,744,239, use patent

    patent.txt lines 4,779, 4,784
    Flags
    use code U-1857
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,750,785, product patent

    patent.txt lines 4,780, 4,785
    Flags
    product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,919,026, product patent

    patent.txt lines 4,789, 4,798, 4,807, 4,816
    Flags
    product
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,925,233, use patent

    patent.txt lines 4,790, 4,799, 4,808, 4,817
    Flags
    use code U-1857
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,925,234, use patent

    patent.txt lines 4,791, 4,800, 4,809, 4,818
    Flags
    use code U-1857
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,937,223, use patent

    patent.txt line 4,786
    Flags
    use code U-1857
    Product numbers
    002
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,962,422, use patent

    patent.txt lines 4,792, 4,801, 4,810, 4,819
    Flags
    use code U-1857
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,968,649, use patent

    patent.txt lines 4,793, 4,802, 4,811, 4,820
    Flags
    use code U-1857
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,974,827, use patent

    patent.txt lines 4,794, 4,803, 4,812, 4,821
    Flags
    use code U-1857
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 204485 · VASOPRESSIN

    US 9,981,006, use patent

    patent.txt lines 4,795, 4,804, 4,813, 4,822
    Flags
    use code U-1857
    Product numbers
    003, 004, 005, 006
  • 30 Jan 2035 · NDA 211765 · UBROGEPANT

    US 10,117,836, product patent

    patent.txt lines 13,155, 13,171
    Flags
    product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 211765 · UBROGEPANT

    US 11,925,709, product patent

    patent.txt lines 13,158, 13,172
    Flags
    product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 211765 · UBROGEPANT

    US 12,168,004, product patent

    patent.txt lines 13,159, 13,174
    Flags
    product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 211765 · UBROGEPANT

    US 12,220,408, product patent

    patent.txt lines 13,162, 13,175
    Flags
    product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 211765 · UBROGEPANT

    US 12,310,953, product patent

    patent.txt lines 13,163, 13,176
    Flags
    product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 211765 · UBROGEPANT

    US 12,458,632, product patent

    patent.txt lines 13,165, 13,177
    Flags
    product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 211765 · UBROGEPANT

    US 12,458,633, product patent

    patent.txt lines 13,166, 13,178
    Flags
    product
    Product numbers
    001, 002
  • 30 Jan 2035 · NDA 213736 · PEMIGATINIB

    US 9,611,267, substance and product patent

    patent.txt lines 15,233, 15,243, 15,253
    Flags
    substance product
    Product numbers
    001, 002, 003
  • 30 Jan 2035 · NDA 215206 · ATOGEPANT

    US 10,117,836, product patent

    patent.txt lines 16,558, 16,567, 16,574
    Flags
    product
    Product numbers
    001, 002, 003
  • 3 Feb 2035 · NDA 202324 · AXITINIB

    US 10,570,202, use patent

    patent.txt lines 3,048, 3,057
    Flags
    use code U-2844
    Product numbers
    001, 002
  • 3 Feb 2035 · NDA 202324 · AXITINIB

    US 12,534,530, use patent

    patent.txt lines 3,052, 3,061
    Flags
    use code U-4411
    Product numbers
    001, 002
  • 3 Feb 2035 · NDA 202324 · AXITINIB

    US 12,534,530, use patent

    patent.txt lines 3,053, 3,062
    Flags
    use code U-4412
    Product numbers
    001, 002
  • 6 Feb 2035 · NDA 213137 · VOXELOTOR

    US 10,722,502, product patent

    patent.txt lines 14,669, 14,682
    Flags
    product
    Product numbers
    001, 002
  • 6 Feb 2035 · NDA 213137 · VOXELOTOR

    US 11,452,720, use patent

    patent.txt lines 14,673, 14,686
    Flags
    use code U-3459
    Product numbers
    001, 002
  • 6 Feb 2035 · NDA 213137 · VOXELOTOR

    US 9,447,071, substance and product patent

    patent.txt lines 14,678, 14,691
    Flags
    substance product
    Product numbers
    001, 002
  • 6 Feb 2035 · NDA 216157 · VOXELOTOR

    US 10,722,502, product patent

    patent.txt line 18,367
    Flags
    product
    Product numbers
    001
  • 6 Feb 2035 · NDA 216157 · VOXELOTOR

    US 11,452,720, use patent

    patent.txt line 18,371
    Flags
    use code U-3459
    Product numbers
    001
  • 6 Feb 2035 · NDA 216157 · VOXELOTOR

    US 9,447,071, substance and product patent

    patent.txt line 18,376
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 205677 · TASIMELTEON

    US 10,071,977, substance and product patent

    patent.txt line 5,760
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 205677 · TASIMELTEON

    US 10,829,465, substance and product patent

    patent.txt line 5,771
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 205677 · TASIMELTEON

    US 11,566,011, substance and product patent

    patent.txt line 5,780
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 205677 · TASIMELTEON

    US 11,760,740, substance and product patent

    patent.txt line 5,784
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 205677 · TASIMELTEON

    US 12,049,457, substance and product patent

    patent.txt line 5,797
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 214517 · TASIMELTEON

    US 10,071,977, substance and product patent

    patent.txt line 15,835
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 214517 · TASIMELTEON

    US 10,829,465, substance and product patent

    patent.txt line 15,841
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 214517 · TASIMELTEON

    US 11,566,011, substance and product patent

    patent.txt line 15,847
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 214517 · TASIMELTEON

    US 11,760,740, substance and product patent

    patent.txt line 15,850
    Flags
    substance product
    Product numbers
    001
  • 12 Feb 2035 · NDA 214517 · TASIMELTEON

    US 12,049,457, substance and product patent

    patent.txt line 15,857
    Flags
    substance product
    Product numbers
    001
  • 17 Feb 2035 · NDA 212725 · ENTRECTINIB

    US 10,231,965, use patent

    patent.txt lines 14,369, 14,388
    Flags
    use code U-2617
    Product numbers
    001, 002
  • 17 Feb 2035 · NDA 212725 · ENTRECTINIB

    US 10,231,965, use patent

    patent.txt lines 14,370, 14,389
    Flags
    use code U-2618
    Product numbers
    001, 002
  • 19 Feb 2035 · NDA 020845 · NITRIC OXIDE

    US 9,279,794, product and use patent

    patent.txt line 241
    Flags
    product use code U-1823
    Product numbers
    003
  • 19 Feb 2035 · NDA 209863 · TESTOSTERONE ENANTHATE

    US 10,238,662, product and use patent

    patent.txt lines 10,916, 10,939, 10,962
    Flags
    product use code U-2418
    Product numbers
    001, 002, 003
  • 19 Feb 2035 · NDA 209863 · TESTOSTERONE ENANTHATE

    US 10,912,782, product and use patent

    patent.txt lines 10,923, 10,946, 10,969
    Flags
    product use code U-2418
    Product numbers
    001, 002, 003
  • 19 Feb 2035 · NDA 212725 · ENTRECTINIB

    US 10,561,651, use patent

    patent.txt lines 14,372, 14,391
    Flags
    use code U-2745
    Product numbers
    001, 002
  • 20 Feb 2035 · NDA 206976 · DICLOFENAC EPOLAMINE

    US 11,344,520, use patent

    patent.txt line 6,918
    Flags
    use code U-3393
    Product numbers
    001
  • 20 Feb 2035 · NDA 206976 · DICLOFENAC EPOLAMINE

    US 11,351,133, use patent

    patent.txt line 6,919
    Flags
    use code U-3393
    Product numbers
    001
  • 20 Feb 2035 · NDA 214375 · XENON XE-129 HYPERPOLARIZED

    US 10,583,205, product patent

    patent.txt line 15,734
    Flags
    product
    Product numbers
    001
  • 25 Feb 2035 · NDA 209863 · TESTOSTERONE ENANTHATE

    US 11,813,435, product patent

    patent.txt lines 10,929, 10,952, 10,975
    Flags
    product
    Product numbers
    001, 002, 003
  • 25 Feb 2035 · NDA 211566 · SITAGLIPTIN

    US 10,925,871, product patent

    patent.txt lines 12,882–12,884
    Flags
    product
    Product numbers
    001, 002, 003
  • 26 Feb 2035 · NDA 215700 · NOREPINEPHRINE BITARTRATE

    US RE49422, product patent

    patent.txt lines 17,484, 17,486, 17,488, 17,491
    Flags
    product
    Product numbers
    001, 002, 003, 004
  • 26 Feb 2035 · NDA 215700 · NOREPINEPHRINE BITARTRATE

    US RE49443, product patent

    patent.txt lines 17,489, 17,492
    Flags
    product
    Product numbers
    003, 004
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 10,098,863, product and use patent

    patent.txt line 11,279
    Flags
    product use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 10,105,335, product patent

    patent.txt line 11,280
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 10,105,336, product and use patent

    patent.txt line 11,281
    Flags
    product use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 10,105,337, product patent

    patent.txt line 11,282
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 10,918,615, product and use patent

    patent.txt line 11,283
    Flags
    product use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 10,918,616, use patent

    patent.txt line 11,284
    Flags
    use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 10,918,617, product patent

    patent.txt line 11,285
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 10,945,985, product patent

    patent.txt line 11,286
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 11,590,095, use patent

    patent.txt line 11,287
    Flags
    use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 11,903,918, use patent

    patent.txt line 11,288
    Flags
    use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,326,947, product patent

    patent.txt line 11,289
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,326,965, use patent

    patent.txt line 11,290
    Flags
    use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,511,043, use patent

    patent.txt line 11,291
    Flags
    use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,517,209, product patent

    patent.txt line 11,292
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,566,259, product patent

    patent.txt line 11,293
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,636,318, use patent

    patent.txt line 11,294
    Flags
    use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,636,319, product patent

    patent.txt line 11,295
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,814,691, use patent

    patent.txt line 11,296
    Flags
    use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,814,692, use patent

    patent.txt line 11,297
    Flags
    use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,820,960, product patent

    patent.txt line 11,298
    Flags
    product
    Product numbers
    001
  • 27 Feb 2035 · NDA 210296 · MONOMETHYL FUMARATE

    US 9,820,961, product and use patent

    patent.txt line 11,299
    Flags
    product use code U-1384
    Product numbers
    001
  • 27 Feb 2035 · NDA 215809 · LEVOTHYROXINE SODIUM

    US 9,345,772, product patent

    patent.txt line 17,517
    Flags
    product
    Product numbers
    001
  • 9 Mar 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 10,329,260, substance patent

    patent.txt lines 15,466, 15,498
    Flags
    substance
    Product numbers
    001, 002
  • 9 Mar 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 10,689,346, use patent

    patent.txt lines 15,470, 15,502
    Flags
    use code U-3010
    Product numbers
    001, 002
  • 9 Mar 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 11,230,530, use patent

    patent.txt lines 15,474, 15,506
    Flags
    use code U-3300
    Product numbers
    001, 002
  • 9 Mar 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 11,708,333, use patent

    patent.txt lines 15,478, 15,510
    Flags
    use code U-3300
    Product numbers
    001, 002
  • 9 Mar 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,116,346, substance patent

    patent.txt lines 15,480, 15,512
    Flags
    substance
    Product numbers
    001, 002
  • 9 Mar 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 10,329,260, substance patent

    patent.txt lines 21,883, 21,915, 21,947, 21,979
    Flags
    substance
    Product numbers
    001, 002, 003, 004
  • 9 Mar 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 10,689,346, use patent

    patent.txt lines 21,887, 21,919, 21,951, 21,983
    Flags
    use code U-4535
    Product numbers
    001, 002, 003, 004
  • 9 Mar 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 11,230,530, use patent

    patent.txt lines 21,891, 21,923, 21,955, 21,987
    Flags
    use code U-4535
    Product numbers
    001, 002, 003, 004
  • 9 Mar 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 11,708,333, use patent

    patent.txt lines 21,895, 21,927, 21,959, 21,991
    Flags
    use code U-4535
    Product numbers
    001, 002, 003, 004
  • 9 Mar 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 12,116,346, substance patent

    patent.txt lines 21,897, 21,929, 21,961, 21,993
    Flags
    substance
    Product numbers
    001, 002, 003, 004
  • 11 Mar 2035 · NDA 209483 · CLOBETASOL PROPIONATE

    US 9,855,334, product patent

    patent.txt line 10,427
    Flags
    product
    Product numbers
    001
  • 12 Mar 2035 · NDA 217673 · BRENSOCATIB

    US 9,522,894, substance patent

    patent.txt lines 20,222, 20,236
    Flags
    substance
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 204063 · DIMETHYL FUMARATE

    US 10,391,160, use patent

    patent.txt lines 4,253, 4,262
    Flags
    use code U-3148
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 204063 · DIMETHYL FUMARATE

    US 10,555,993, use patent

    patent.txt lines 4,254, 4,263
    Flags
    use code U-3148
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 204063 · DIMETHYL FUMARATE

    US 10,994,003, use patent

    patent.txt lines 4,256, 4,265
    Flags
    use code U-3148
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 204200 · EPINEPHRINE

    US 12,280,024, product patent

    patent.txt line 4,349
    Flags
    product
    Product numbers
    001
  • 13 Mar 2035 · NDA 204200 · EPINEPHRINE

    US 9,119,876, product patent

    patent.txt line 4,350
    Flags
    product
    Product numbers
    001
  • 13 Mar 2035 · NDA 204200 · EPINEPHRINE

    US 9,295,657, use patent

    patent.txt line 4,351
    Flags
    use code U-1829
    Product numbers
    001
  • 13 Mar 2035 · NDA 204640 · EPINEPHRINE

    US 10,130,592, product patent

    patent.txt line 4,940
    Flags
    product
    Product numbers
    001
  • 13 Mar 2035 · NDA 204640 · EPINEPHRINE

    US 12,280,024, product patent

    patent.txt line 4,941
    Flags
    product
    Product numbers
    001
  • 13 Mar 2035 · NDA 204640 · EPINEPHRINE

    US 9,119,876, product patent

    patent.txt line 4,942
    Flags
    product
    Product numbers
    001
  • 13 Mar 2035 · NDA 204640 · EPINEPHRINE

    US 9,295,657, use patent

    patent.txt line 4,943
    Flags
    use code U-1829
    Product numbers
    001
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,493,028, product patent

    patent.txt lines 9,589, 9,599
    Flags
    product
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,688,046, product patent

    patent.txt lines 9,590, 9,600
    Flags
    product
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,959,946, product patent

    patent.txt lines 9,591, 9,601
    Flags
    product
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,959,947, product and use patent

    patent.txt lines 9,592, 9,602
    Flags
    product use code U-3104
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,959,947, product and use patent

    patent.txt lines 9,593, 9,603
    Flags
    product use code U-3105
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,959,948, product and use patent

    patent.txt lines 9,594, 9,604
    Flags
    product use code U-3104
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,959,948, product and use patent

    patent.txt lines 9,595, 9,605
    Flags
    product use code U-3105
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,959,949, product and use patent

    patent.txt lines 9,596, 9,606
    Flags
    product use code U-3104
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 10,959,949, product and use patent

    patent.txt lines 9,597, 9,607
    Flags
    product use code U-3105
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 208910 · VANCOMYCIN HYDROCHLORIDE

    US 11,638,692, product patent

    patent.txt lines 9,598, 9,608
    Flags
    product
    Product numbers
    001, 002
  • 13 Mar 2035 · NDA 211192 · IVOSIDENIB

    US 10,449,184, product patent

    patent.txt line 12,510
    Flags
    product
    Product numbers
    001
  • 13 Mar 2035 · NDA 211192 · IVOSIDENIB

    US 10,799,490, product and use patent

    patent.txt line 12,516
    Flags
    product use code U-2981
    Product numbers
    001
  • 13 Mar 2035 · NDA 211192 · IVOSIDENIB

    US 10,799,490, product and use patent

    patent.txt line 12,517
    Flags
    product use code U-2982
    Product numbers
    001
  • 13 Mar 2035 · NDA 211192 · IVOSIDENIB

    US 10,799,490, product and use patent

    patent.txt line 12,518
    Flags
    product use code U-3384
    Product numbers
    001
  • 13 Mar 2035 · NDA 211192 · IVOSIDENIB

    US 9,968,595, product and use patent

    patent.txt line 12,537
    Flags
    product use code U-2351
    Product numbers
    001
  • 13 Mar 2035 · NDA 211192 · IVOSIDENIB

    US 9,968,595, product and use patent

    patent.txt line 12,538
    Flags
    product use code U-2533
    Product numbers
    001
  • 13 Mar 2035 · NDA 211192 · IVOSIDENIB

    US 9,968,595, product and use patent

    patent.txt line 12,539
    Flags
    product use code U-2534
    Product numbers
    001
  • 13 Mar 2035 · NDA 211192 · IVOSIDENIB

    US 9,968,595, product and use patent

    patent.txt line 12,540
    Flags
    product use code U-3384
    Product numbers
    001
  • 19 Mar 2035 · NDA 207533 · ARIPIPRAZOLE LAUROXIL

    US 10,238,651, use patent

    patent.txt lines 7,276, 7,293, 7,311, 7,329
    Flags
    use code U-2402
    Product numbers
    001, 002, 003, 004
  • 19 Mar 2035 · NDA 207533 · ARIPIPRAZOLE LAUROXIL

    US 10,813,928, use patent

    patent.txt lines 7,277, 7,294, 7,330
    Flags
    use code U-2983
    Product numbers
    001, 002, 004
  • 19 Mar 2035 · NDA 207533 · ARIPIPRAZOLE LAUROXIL

    US 10,813,928, use patent

    patent.txt line 7,312
    Flags
    use code U-2402
    Product numbers
    003
  • 19 Mar 2035 · NDA 207533 · ARIPIPRAZOLE LAUROXIL

    US 11,406,632, use patent

    patent.txt lines 7,280, 7,297, 7,315, 7,333
    Flags
    use code U-2402
    Product numbers
    001, 002, 003, 004
  • 19 Mar 2035 · NDA 207533 · ARIPIPRAZOLE LAUROXIL

    US 12,653,822, use patent

    patent.txt lines 7,285, 7,302, 7,320, 7,338
    Flags
    use code U-2402
    Product numbers
    001, 002, 003, 004
  • 19 Mar 2035 · NDA 207533 · ARIPIPRAZOLE LAUROXIL

    US 9,452,131, use patent

    patent.txt lines 7,290, 7,307, 7,325, 7,343
    Flags
    use code U-2402
    Product numbers
    001, 002, 003, 004
  • 19 Mar 2035 · NDA 207533 · ARIPIPRAZOLE LAUROXIL

    US 9,526,726, product patent

    patent.txt lines 7,308, 7,326
    Flags
    product
    Product numbers
    002, 003
  • 19 Mar 2035 · NDA 217899 · SELADELPAR LYSINE

    US 11,406,611, use patent

    patent.txt line 20,753
    Flags
    use code U-1854
    Product numbers
    001
  • 19 Mar 2035 · NDA 217899 · SELADELPAR LYSINE

    US 11,596,614, use patent

    patent.txt line 20,754
    Flags
    use code U-1854
    Product numbers
    001
  • 19 Mar 2035 · NDA 217899 · SELADELPAR LYSINE

    US 9,486,428, use patent

    patent.txt line 20,757
    Flags
    use code U-1854
    Product numbers
    001
  • 20 Mar 2035 · NDA 205787 · NALOXONE HYDROCHLORIDE

    US 10,220,158, product and use patent

    patent.txt line 5,872
    Flags
    product use code U-2500
    Product numbers
    001
  • 20 Mar 2035 · NDA 209862 · NALOXONE HYDROCHLORIDE

    US 10,220,158, product and use patent

    patent.txt line 10,896
    Flags
    product use code U-2500
    Product numbers
    001
  • 22 Mar 2035 · NDA 214231 · DASIGLUCAGON HYDROCHLORIDE

    US 10,442,847, substance and product patent

    patent.txt lines 15,649, 15,651
    Flags
    substance product
    Product numbers
    001, 002
  • 26 Mar 2035 · NDA 212018 · ERDAFITINIB

    US 9,902,714, product patent

    patent.txt lines 13,399, 13,417, 13,435
    Flags
    product
    Product numbers
    001, 002, 003
  • 26 Mar 2035 · NDA 215179 · PEMETREXED DISODIUM

    US 11,147,817, product patent

    patent.txt lines 16,513–16,515
    Flags
    product
    Product numbers
    001, 002, 003
  • 31 Mar 2035 · NDA 207233 · MELOXICAM

    US 9,649,318, product patent

    patent.txt lines 7,225, 7,229
    Flags
    product
    Product numbers
    001, 002
  • 31 Mar 2035 · NDA 207233 · MELOXICAM

    US 9,808,468, use patent

    patent.txt lines 7,226, 7,230
    Flags
    use code U-2160
    Product numbers
    001, 002
  • 31 Mar 2035 · NDA 207233 · MELOXICAM

    US 9,808,468, use patent

    patent.txt lines 7,227, 7,231
    Flags
    use code U-2165
    Product numbers
    001, 002
  • 1 Apr 2035 · NDA 214324 · TREPROSTINIL

    US 10,421,729, product patent

    patent.txt lines 15,675, 15,683, 15,691, 15,699, 15,707
    Flags
    product
    Product numbers
    001, 002, 003, 004, 005
  • 1 Apr 2035 · NDA 215887 · TOFERSEN

    US 10,385,341, substance and product patent

    patent.txt line 18,071
    Flags
    substance product
    Product numbers
    001
  • 1 Apr 2035 · NDA 215887 · TOFERSEN

    US 10,669,546, use patent

    patent.txt line 18,072
    Flags
    use code U-3575
    Product numbers
    001
  • 1 Apr 2035 · NDA 215887 · TOFERSEN

    US 10,968,453, use patent

    patent.txt line 18,073
    Flags
    use code U-3575
    Product numbers
    001
  • 2 Apr 2035 · NDA 211964 · VILOXAZINE HYDROCHLORIDE

    US 9,662,338, product patent

    patent.txt lines 13,297, 13,303, 13,309
    Flags
    product
    Product numbers
    001, 002, 003
  • 7 Apr 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE

    US 10,125,102, substance and use patent

    patent.txt lines 15,464, 15,496
    Flags
    substance use code U-3010
    Product numbers
    001, 002
  • 7 Apr 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE

    US 10,125,102, substance and use patent

    patent.txt lines 21,881, 21,913, 21,945, 21,977
    Flags
    substance use code U-4535
    Product numbers
    001, 002, 003, 004
  • 9 Apr 2035 · NDA 214783 · BELUMOSUDIL MESYLATE

    US 11,311,541, use patent

    patent.txt line 16,118
    Flags
    use code U-3369
    Product numbers
    001
  • 11 Apr 2035 · NDA 216196 · MITAPIVAT SULFATE

    US RE49582, substance and product patent

    patent.txt lines 18,440, 18,449, 18,458, 18,464
    Flags
    substance product
    Product numbers
    001, 002, 003, 004
  • 14 Apr 2035 · NDA 210491 · IVACAFTOR; IVACAFTOR, TEZACAFTOR

    US 10,206,877, product and use patent

    patent.txt lines 11,420, 11,453
    Flags
    product use code U-3026
    Product numbers
    001, 002
  • 14 Apr 2035 · NDA 210491 · IVACAFTOR; IVACAFTOR, TEZACAFTOR

    US 10,206,877, product and use patent

    patent.txt lines 11,421, 11,454
    Flags
    product use code U-3027
    Product numbers
    001, 002
  • 14 Apr 2035 · NDA 210491 · IVACAFTOR; IVACAFTOR, TEZACAFTOR

    US 11,951,212, product and use patent

    patent.txt line 11,428
    Flags
    product use code U-3894
    Product numbers
    001
  • 14 Apr 2035 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM

    US 10,206,877, product and use patent

    patent.txt line 21,232
    Flags
    product use code U-4092
    Product numbers
    002
  • 14 Apr 2035 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM

    US 10,206,877, product and use patent

    patent.txt line 21,233
    Flags
    product use code U-4467
    Product numbers
    002
  • 14 Apr 2035 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM

    US 11,951,212, product and use patent

    patent.txt line 21,248
    Flags
    product use code U-4089
    Product numbers
    002
  • 14 Apr 2035 · NDA 218730 · DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM

    US 11,951,212, product and use patent

    patent.txt line 21,249
    Flags
    product use code U-4461
    Product numbers
    002
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 10,098,957, use patent

    patent.txt lines 13,311, 13,327, 13,343, 13,359
    Flags
    use code U-3118
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 10,213,510, product and use patent

    patent.txt lines 13,312, 13,328, 13,344, 13,360
    Flags
    product use code U-3118
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 10,632,199, product and use patent

    patent.txt lines 13,314, 13,330, 13,346, 13,362
    Flags
    product use code U-3118
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 10,898,575, product and use patent

    patent.txt lines 13,315, 13,331, 13,347, 13,363
    Flags
    product use code U-3118
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 10,980,886, product patent

    patent.txt lines 13,316, 13,332, 13,348, 13,364
    Flags
    product
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 11,083,730, product and use patent

    patent.txt lines 13,317, 13,333, 13,349, 13,365
    Flags
    product use code U-3118
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 11,083,797, product and use patent

    patent.txt lines 13,318, 13,334, 13,350, 13,366
    Flags
    product use code U-3118
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 11,413,350, use patent

    patent.txt lines 13,320, 13,336, 13,352, 13,368
    Flags
    use code U-3417
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 9,694,079, product and use patent

    patent.txt lines 13,323, 13,339, 13,355, 13,371
    Flags
    product use code U-3118
    Product numbers
    001, 002, 003, 004
  • 20 Apr 2035 · NDA 211988 · BUPIVACAINE; MELOXICAM

    US 9,801,945, product and use patent

    patent.txt lines 13,325, 13,341, 13,357, 13,373
    Flags
    product use code U-3118
    Product numbers
    001, 002, 003, 004
  • 21 Apr 2035 · NDA 209305 · HYDROGEN PEROXIDE

    US 10,098,910, product and use patent

    patent.txt line 10,066
    Flags
    product use code U-2205
    Product numbers
    001
  • 21 Apr 2035 · NDA 209305 · HYDROGEN PEROXIDE

    US 10,493,103, product patent

    patent.txt line 10,067
    Flags
    product
    Product numbers
    001
  • 21 Apr 2035 · NDA 209305 · HYDROGEN PEROXIDE

    US 10,729,720, product patent

    patent.txt line 10,068
    Flags
    product
    Product numbers
    001
  • 21 Apr 2035 · NDA 209305 · HYDROGEN PEROXIDE

    US 9,980,983, use patent

    patent.txt line 10,070
    Flags
    use code U-2205
    Product numbers
    001
  • 24 Apr 2035 · NDA 205637 · BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

    US 9,522,188, product patent

    patent.txt lines 5,700, 5,704, 5,708
    Flags
    product
    Product numbers
    001, 002, 003
  • 24 Apr 2035 · NDA 208434 · ALECTINIB HYDROCHLORIDE

    US 10,350,214, product patent

    patent.txt line 8,616
    Flags
    product
    Product numbers
    001
  • 24 Apr 2035 · NDA 208434 · ALECTINIB HYDROCHLORIDE

    US 11,433,076, product patent

    patent.txt line 8,617
    Flags
    product
    Product numbers
    001
  • 25 Apr 2035 · NDA 203567 · EFINACONAZOLE

    US 10,478,601, product and use patent

    patent.txt line 4,089
    Flags
    product use code U-2721
    Product numbers
    001
  • 26 Apr 2035 · NDA 211155 · DUVELISIB

    US 12,213,983, use patent

    patent.txt lines 12,491, 12,499
    Flags
    use code U-2412
    Product numbers
    001, 002
  • 27 Apr 2035 · NDA 022114 · LIDOCAINE HYDROCHLORIDE

    US 9,358,338, use patent

    patent.txt line 1,082
    Flags
    use code U-1870
    Product numbers
    001
  • 1 May 2035 · NDA 212595 · METFORMIN HYDROCHLORIDE

    US 9,962,336, product patent

    patent.txt line 14,185
    Flags
    product
    Product numbers
    001
  • 1 May 2035 · NDA 219407 · DONIDALORSEN SODIUM

    US 10,294,477, substance and product and use patent

    patent.txt line 21,725
    Flags
    substance product use code U-3010
    Product numbers
    001
  • 4 May 2035 · NDA 212279 · AIR POLYMER-TYPE A

    US 9,259,494, product and use patent

    patent.txt line 13,796
    Flags
    product use code U-2663
    Product numbers
    001
  • 7 May 2035 · NDA 212994 · DEXMETHYLPHENIDATE HYDROCHLORIDE; SERDEXMETHYLPHENIDATE CHLORIDE

    US 9,079,928, product patent

    patent.txt lines 14,520, 14,526, 14,532
    Flags
    product
    Product numbers
    001, 002, 003
  • 8 May 2035 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR

    US RE48923, substance patent

    patent.txt line 10,323
    Flags
    substance
    Product numbers
    001
  • 8 May 2035 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR

    US RE48923, substance patent

    patent.txt line 16,496
    Flags
    substance
    Product numbers
    001
  • 11 May 2035 · NDA 213535 · RISDIPLAM

    US 9,969,754, substance and product and use patent

    patent.txt line 15,086
    Flags
    substance product use code U-1943
    Product numbers
    001
  • 11 May 2035 · NDA 219285 · RISDIPLAM

    US 9,969,754, substance and product and use patent

    patent.txt line 21,577
    Flags
    substance product use code U-1943
    Product numbers
    001
  • 13 May 2035 · NDA 215310 · MOBOCERTINIB SUCCINATE

    US 10,227,342, substance and product and use patent

    patent.txt line 16,771
    Flags
    substance product use code U-3220
    Product numbers
    001
  • 13 May 2035 · NDA 215310 · MOBOCERTINIB SUCCINATE

    US 9,796,712, substance and product patent

    patent.txt line 16,772
    Flags
    substance product
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 10,251,900, use patent

    patent.txt line 7,246
    Flags
    use code U-2414
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 10,751,355, use patent

    patent.txt line 7,247
    Flags
    use code U-2414
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 11,446,318, use patent

    patent.txt line 7,248
    Flags
    use code U-2414
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 12,016,873, use patent

    patent.txt line 7,249
    Flags
    use code U-2414
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 12,168,021, use patent

    patent.txt line 7,250
    Flags
    use code U-2414
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 12,168,022, use patent

    patent.txt line 7,251
    Flags
    use code U-2414
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 12,377,114, use patent

    patent.txt line 7,252
    Flags
    use code U-2414
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 12,616,708, use patent

    patent.txt line 7,253
    Flags
    use code U-2414
    Product numbers
    001
  • 15 May 2035 · NDA 207356 · AMIKACIN SULFATE

    US 9,895,385, use patent

    patent.txt line 7,259
    Flags
    use code U-2417
    Product numbers
    001
  • 26 May 2035 · NDA 213176 · UMBRALISIB TOSYLATE

    US 10,414,773, substance and product and use patent

    patent.txt line 14,707
    Flags
    substance product use code U-3063
    Product numbers
    001
  • 26 May 2035 · NDA 213176 · UMBRALISIB TOSYLATE

    US 10,414,773, substance and product and use patent

    patent.txt line 14,708
    Flags
    substance product use code U-3064
    Product numbers
    001
  • 26 May 2035 · NDA 213176 · UMBRALISIB TOSYLATE

    US 10,947,244, use patent

    patent.txt line 14,711
    Flags
    use code U-3063
    Product numbers
    001
  • 26 May 2035 · NDA 213176 · UMBRALISIB TOSYLATE

    US 10,947,244, use patent

    patent.txt line 14,712
    Flags
    use code U-3064
    Product numbers
    001
  • 26 May 2035 · NDA 213176 · UMBRALISIB TOSYLATE

    US 9,969,740, substance and product and use patent

    patent.txt line 14,718
    Flags
    substance product use code U-3063
    Product numbers
    001
  • 26 May 2035 · NDA 213176 · UMBRALISIB TOSYLATE

    US 9,969,740, substance and product and use patent

    patent.txt line 14,719
    Flags
    substance product use code U-3064
    Product numbers
    001
  • 28 May 2035 · NDA 212905 · CANTHARIDIN

    US 11,052,064, product and use patent

    patent.txt line 14,500
    Flags
    product use code U-3663
    Product numbers
    001
  • 28 May 2035 · NDA 212905 · CANTHARIDIN

    US 11,052,064, product and use patent

    patent.txt line 14,501
    Flags
    product use code U-3665
    Product numbers
    001
  • 29 May 2035 · NDA 211913 · ISOTRETINOIN

    US 9,750,711, product patent

    patent.txt lines 13,231, 13,233, 13,235, 13,237, 13,239, 13,241
    Flags
    product
    Product numbers
    001, 002, 003, 004, 005, 006
  • 5 Jun 2035 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR

    US 9,321,807, substance patent

    patent.txt line 10,317
    Flags
    substance
    Product numbers
    001
  • 5 Jun 2035 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR

    US 9,321,807, substance and product patent

    patent.txt line 16,491
    Flags
    substance product
    Product numbers
    001
  • 9 Jun 2035 · NDA 220496 · FLORQUINITAU F-18

    US 10,022,461, use patent

    patent.txt line 22,292
    Flags
    use code U-4597
    Product numbers
    001
  • 9 Jun 2035 · NDA 220496 · FLORQUINITAU F-18

    US 9,808,542, substance and product and use patent

    patent.txt line 22,293
    Flags
    substance product use code U-4597
    Product numbers
    001
  • 10 Jun 2035 · NDA 215092 · OMIDENEPAG ISOPROPYL

    US 10,774,072, substance patent

    patent.txt line 16,466
    Flags
    substance
    Product numbers
    001
  • 11 Jun 2035 · NDA 208552 · OXYMETAZOLINE HYDROCHLORIDE

    US 10,335,391, use patent

    patent.txt line 8,673
    Flags
    use code U-2567
    Product numbers
    001
  • 11 Jun 2035 · NDA 208552 · OXYMETAZOLINE HYDROCHLORIDE

    US 10,751,325, use patent

    patent.txt line 8,674
    Flags
    use code U-2921
    Product numbers
    001
  • 11 Jun 2035 · NDA 208552 · OXYMETAZOLINE HYDROCHLORIDE

    US 11,517,560, use patent

    patent.txt line 8,675
    Flags
    use code U-3494
    Product numbers
    001
  • 11 Jun 2035 · NDA 208552 · OXYMETAZOLINE HYDROCHLORIDE

    US 12,350,255, use patent

    patent.txt line 8,676
    Flags
    use code U-3494
    Product numbers
    001
  • 11 Jun 2035 · NDA 208552 · OXYMETAZOLINE HYDROCHLORIDE

    US 9,974,773, use patent

    patent.txt line 8,679
    Flags
    use code U-2306
    Product numbers
    001
  • 11 Jun 2035 · NDA 214938 · VOSORITIDE

    US 8,198,242, substance and product and use patent

    patent.txt lines 16,358, 16,366, 16,374
    Flags
    substance product use code U-3927
    Product numbers
    001, 002, 003
  • 11 Jun 2035 · NDA 216873 · MOMELOTINIB DIHYDROCHLORIDE

    US 9,809,559, use patent

    patent.txt lines 19,027, 19,032, 19,037
    Flags
    use code U-1201
    Product numbers
    001, 002, 003
  • 11 Jun 2035 · NDA 216873 · MOMELOTINIB DIHYDROCHLORIDE

    US RE48285, substance and product and use patent

    patent.txt lines 19,028, 19,033, 19,038
    Flags
    substance product use code U-1201
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 10,106,579, substance and product and use patent

    patent.txt lines 18,997, 19,006, 19,015
    Flags
    substance product use code U-3735
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 10,208,089, substance and use patent

    patent.txt lines 18,998, 19,007, 19,016
    Flags
    substance use code U-3735
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 10,435,438, substance and use patent

    patent.txt lines 18,999, 19,008, 19,017
    Flags
    substance use code U-3735
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 10,562,934, substance patent

    patent.txt lines 19,000, 19,009, 19,018
    Flags
    substance
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 10,835,574, product patent

    patent.txt lines 19,001, 19,010, 19,019
    Flags
    product
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 11,014,965, substance and use patent

    patent.txt lines 19,002, 19,011, 19,020
    Flags
    substance use code U-3735
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 11,535,650, product patent

    patent.txt lines 19,003, 19,012, 19,021
    Flags
    product
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 11,752,190, product and use patent

    patent.txt lines 19,004, 19,013, 19,022
    Flags
    product use code U-3735
    Product numbers
    001, 002, 003
  • 12 Jun 2035 · NDA 216834 · ZILUCOPLAN SODIUM

    US 11,965,040, product patent

    patent.txt lines 19,005, 19,014, 19,023
    Flags
    product
    Product numbers
    001, 002, 003
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,092,525, use patent

    patent.txt line 11,319
    Flags
    use code U-2427
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,111,840, use patent

    patent.txt line 11,320
    Flags
    use code U-2442
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,111,840, use patent

    patent.txt line 11,321
    Flags
    use code U-2443
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,137,095, use patent

    patent.txt line 11,322
    Flags
    use code U-2454
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,137,095, use patent

    patent.txt line 11,323
    Flags
    use code U-2455
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,603,288, use patent

    patent.txt line 11,324
    Flags
    use code U-2780
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,603,288, use patent

    patent.txt line 11,325
    Flags
    use code U-2781
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,603,288, use patent

    patent.txt line 11,326
    Flags
    use code U-2782
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,603,288, use patent

    patent.txt line 11,327
    Flags
    use code U-2783
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,709,671, use patent

    patent.txt line 11,328
    Flags
    use code U-2862
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,709,673, product patent

    patent.txt line 11,329
    Flags
    product
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,709,674, use patent

    patent.txt line 11,330
    Flags
    use code U-2780
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,709,674, use patent

    patent.txt line 11,331
    Flags
    use code U-2781
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,849,860, use patent

    patent.txt line 11,332
    Flags
    use code U-2427
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,849,860, use patent

    patent.txt line 11,333
    Flags
    use code U-2454
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,966,939, product and use patent

    patent.txt line 11,337
    Flags
    product use code U-2780
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 10,966,939, product and use patent

    patent.txt line 11,338
    Flags
    product use code U-2781
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,154,516, use patent

    patent.txt line 11,342
    Flags
    use code U-3235
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,154,516, use patent

    patent.txt line 11,343
    Flags
    use code U-3236
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,311,498, use patent

    patent.txt line 11,348
    Flags
    use code U-3375
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,311,498, use patent

    patent.txt line 11,349
    Flags
    use code U-3376
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,357,741, use patent

    patent.txt line 11,350
    Flags
    use code U-2862
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,446,258, use patent

    patent.txt line 11,353
    Flags
    use code U-2780
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,446,258, use patent

    patent.txt line 11,354
    Flags
    use code U-2781
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,446,258, use patent

    patent.txt line 11,355
    Flags
    use code U-3071
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,633,369, product and use patent

    patent.txt line 11,356
    Flags
    product use code U-2780
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,633,369, product and use patent

    patent.txt line 11,357
    Flags
    product use code U-2781
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,633,369, product and use patent

    patent.txt line 11,358
    Flags
    product use code U-3071
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,701,330, use patent

    patent.txt line 11,359
    Flags
    use code U-2780
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,701,330, use patent

    patent.txt line 11,360
    Flags
    use code U-2781
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,766,411, use patent

    patent.txt line 11,361
    Flags
    use code U-2781
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,963,937, use patent

    patent.txt line 11,365
    Flags
    use code U-2780
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 11,963,937, use patent

    patent.txt line 11,366
    Flags
    use code U-2781
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 12,064,399, use patent

    patent.txt line 11,367
    Flags
    use code U-3988
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 12,064,399, use patent

    patent.txt line 11,368
    Flags
    use code U-3989
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 9,949,937, use patent

    patent.txt line 11,373
    Flags
    use code U-2421
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 9,956,183, use patent

    patent.txt line 11,374
    Flags
    use code U-2422
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 9,956,183, use patent

    patent.txt line 11,375
    Flags
    use code U-2423
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 9,956,184, use patent

    patent.txt line 11,376
    Flags
    use code U-2424
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 9,956,185, use patent

    patent.txt line 11,377
    Flags
    use code U-2425
    Product numbers
    001
  • 17 Jun 2035 · NDA 210365 · CANNABIDIOL

    US 9,956,186, use patent

    patent.txt line 11,378
    Flags
    use code U-2426
    Product numbers
    001
  • 18 Jun 2035 · NDA 218585 · ACECLIDINE HYDROCHLORIDE

    US 12,653,779, use patent

    patent.txt line 21,127
    Flags
    use code U-3741
    Product numbers
    001
  • 19 Jun 2035 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

    US 10,385,067, use patent

    patent.txt lines 11,211, 11,222
    Flags
    use code U-257
    Product numbers
    001, 002
  • 19 Jun 2035 · NDA 210251 · BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE

    US 9,708,342, substance and product patent

    patent.txt lines 11,220, 11,229
    Flags
    substance product
    Product numbers
    001, 002
  • 19 Jun 2035 · NDA 221104 · BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM

    US 10,385,067, use patent

    patent.txt line 22,422
    Flags
    use code U-4602
    Product numbers
    001
  • 19 Jun 2035 · NDA 221104 · BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM

    US 9,708,342, substance and product patent

    patent.txt line 22,426
    Flags
    substance product
    Product numbers
    001
  • 19 Jun 2035 · NDA 221443 · BICTEGRAVIR SODIUM, LENACAPAVIR SODIUM; LENACAPAVIR SODIUM

    US 10,385,067, use patent

    patent.txt line 22,432
    Flags
    use code U-4602
    Product numbers
    001
  • 19 Jun 2035 · NDA 221443 · BICTEGRAVIR SODIUM, LENACAPAVIR SODIUM; LENACAPAVIR SODIUM

    US 9,708,342, substance and product patent

    patent.txt line 22,436
    Flags
    substance product
    Product numbers
    001
  • 23 Jun 2035 · NDA 217700 · TOVORAFENIB

    US 10,426,782, product patent

    patent.txt line 20,334
    Flags
    product
    Product numbers
    001
  • 23 Jun 2035 · NDA 218033 · TOVORAFENIB

    US 10,426,782, product patent

    patent.txt line 20,784
    Flags
    product
    Product numbers
    001
  • 26 Jun 2035 · NDA 210735 · CYCLOPHOSPHAMIDE

    US 9,662,342, product patent

    patent.txt lines 12,126–12,128
    Flags
    product
    Product numbers
    001, 002, 003

Pediatric exclusivity, as listed (17)

  • 7 Feb 2035 · NDA 209092 · RIBOCICLIB SUCCINATE

    US 12,544,379 with pediatric exclusivity, as listed

    patent.txt line 9,691
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 7 Feb 2035 · NDA 209092 · RIBOCICLIB SUCCINATE

    US 12,544,380 with pediatric exclusivity, as listed

    patent.txt line 9,693
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 7 Feb 2035 · NDA 209935 · LETROZOLE; RIBOCICLIB SUCCINATE

    US 12,544,380 with pediatric exclusivity, as listed

    patent.txt line 11,038
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 9 Mar 2035 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

    US 10,376,496 with pediatric exclusivity, as listed

    patent.txt line 6,775
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 9 Mar 2035 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

    US 10,933,053 with pediatric exclusivity, as listed

    patent.txt line 6,787
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 6 Apr 2035 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

    US 9,066,957 with pediatric exclusivity, as listed

    patent.txt lines 9,523, 9,531, 9,537, 9,549, 9,563, 9,575
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004, 005, 006
  • 6 Apr 2035 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

    US 9,415,008 with pediatric exclusivity, as listed

    patent.txt lines 9,525, 9,551
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 004
  • 24 Apr 2035 · NDA 205552 · IBRUTINIB

    US 10,463,668 with pediatric exclusivity, as listed

    patent.txt lines 5,482, 5,581
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 24 Apr 2035 · NDA 205552 · IBRUTINIB

    US 10,695,350 with pediatric exclusivity, as listed

    patent.txt lines 5,492, 5,591
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 24 Apr 2035 · NDA 205552 · IBRUTINIB

    US 9,795,604 with pediatric exclusivity, as listed

    patent.txt lines 5,557, 5,655
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002
  • 24 Apr 2035 · NDA 210563 · IBRUTINIB

    US 10,463,668 with pediatric exclusivity, as listed

    patent.txt lines 11,602, 11,708, 11,812, 11,916
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 24 Apr 2035 · NDA 210563 · IBRUTINIB

    US 10,695,350 with pediatric exclusivity, as listed

    patent.txt lines 11,612, 11,718, 11,822, 11,929
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 24 Apr 2035 · NDA 210563 · IBRUTINIB

    US 9,795,604 with pediatric exclusivity, as listed

    patent.txt lines 11,683, 11,787, 11,891, 12,000
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001, 002, 003, 004
  • 24 Apr 2035 · NDA 217003 · IBRUTINIB

    US 9,795,604 with pediatric exclusivity, as listed

    patent.txt line 19,224
    Flags
    pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 26 May 2035 · NDA 205109 · FERRIC OXYHYDROXIDE

    US 10,624,855 with pediatric exclusivity, as listed

    patent.txt line 5,215
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 26 May 2035 · NDA 205109 · FERRIC OXYHYDROXIDE

    US 11,234,938 with pediatric exclusivity, as listed

    patent.txt line 5,231
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001
  • 26 May 2035 · NDA 205109 · FERRIC OXYHYDROXIDE

    US 11,446,252 with pediatric exclusivity, as listed

    patent.txt line 5,233
    Flags
    product pediatric, as listed by FDA (from the base row)
    Product numbers
    001

Non-patent exclusivity (2)

  • 22 Mar 2035 · NDA 217417 · REZAFUNGIN ACETATE

    GAIN exclusivity

    exclusivity.txt line 1,874
    Definition
    Generating Antibiotic Incentives Now (to be checked against FDA's list)
    Product numbers
    001
  • 25 Mar 2035 · NDA 218230 · GEPOTIDACIN MESYLATE

    GAIN exclusivity

    exclusivity.txt line 2,132
    Definition
    Generating Antibiotic Incentives Now (to be checked against FDA's list)
    Product numbers
    001